Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Transfusion Medicine Reviews
|
December 8, 2009
The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline
Nadine Shehata, Valerie A Palda, Ralph M Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 13, 2012
Lenalidomide plus melphalan without prednisone for previously untreated older patients with multiple myeloma: a phase II trial
Darrell J White, Nizar J Bahlis, Deb C Marcellus, et al.
The New England Journal of Medicine
|
December 14, 2011
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
The Lancet. Oncology
|
October 23, 2015
Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial
Edward Chow, Ralph M Meyer, Keyue Ding, et al.
Blood
|
January 7, 2012
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Donald M Arnold, Nancy M Heddle, Julie Carruthers, et al.
Leukemia & Lymphoma
|
May 16, 2017
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study<sup></sup>
Tanya Skamene, Michael Crump, Kerry J Savage, et al.
British Journal of Haematology
|
May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes
Susan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 29, 2016
Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22
Rachel McDonald, Keyue Ding, Edward Chow, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
May 4, 2016
Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy
Srinivas Raman, Keyue Ding, Edward Chow, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Transfusion Medicine Reviews
|
December 8, 2009
The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline
Nadine Shehata, Valerie A Palda, Ralph M Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 13, 2012
Lenalidomide plus melphalan without prednisone for previously untreated older patients with multiple myeloma: a phase II trial
Darrell J White, Nizar J Bahlis, Deb C Marcellus, et al.
The New England Journal of Medicine
|
December 14, 2011
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
The Lancet. Oncology
|
October 23, 2015
Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial
Edward Chow, Ralph M Meyer, Keyue Ding, et al.
Blood
|
January 7, 2012
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Donald M Arnold, Nancy M Heddle, Julie Carruthers, et al.
Leukemia & Lymphoma
|
May 16, 2017
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study<sup></sup>
Tanya Skamene, Michael Crump, Kerry J Savage, et al.
British Journal of Haematology
|
May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes
Susan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 29, 2016
Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22
Rachel McDonald, Keyue Ding, Edward Chow, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
May 4, 2016
Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy
Srinivas Raman, Keyue Ding, Edward Chow, et al.
Page
of 8